CIBC Private Wealth Group LLC Buys 4,960 Shares of Synopsys, Inc. $SNPS

CIBC Private Wealth Group LLC lifted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 131.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,737 shares of the semiconductor company’s stock after acquiring an additional 4,960 shares during the quarter. CIBC Private Wealth Group LLC’s holdings in Synopsys were worth $4,311,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Manchester Capital Management LLC lifted its stake in shares of Synopsys by 5.3% in the second quarter. Manchester Capital Management LLC now owns 340 shares of the semiconductor company’s stock worth $174,000 after acquiring an additional 17 shares during the period. Mutual Advisors LLC increased its position in Synopsys by 2.1% during the 3rd quarter. Mutual Advisors LLC now owns 1,157 shares of the semiconductor company’s stock valued at $528,000 after purchasing an additional 24 shares during the period. Alpine Bank Wealth Management raised its holdings in Synopsys by 89.3% during the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after purchasing an additional 25 shares during the last quarter. Valeo Financial Advisors LLC raised its holdings in Synopsys by 3.9% during the 3rd quarter. Valeo Financial Advisors LLC now owns 666 shares of the semiconductor company’s stock worth $329,000 after purchasing an additional 25 shares during the last quarter. Finally, Blume Capital Management Inc. lifted its position in shares of Synopsys by 8.9% in the 3rd quarter. Blume Capital Management Inc. now owns 305 shares of the semiconductor company’s stock worth $150,000 after purchasing an additional 25 shares during the period. 85.47% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Janet Lee sold 250 shares of the stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the transaction, the insider owned 11,959 shares of the company’s stock, valued at $6,338,270. This represents a 2.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.56% of the stock is owned by company insiders.

Synopsys Stock Performance

NASDAQ:SNPS opened at $420.32 on Friday. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The company has a fifty day moving average of $453.33 and a 200-day moving average of $457.49. The firm has a market capitalization of $80.52 billion, a P/E ratio of 65.27, a P/E/G ratio of 3.42 and a beta of 1.15.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.56 by $0.21. The business had revenue of $2.41 billion for the quarter, compared to analyst estimates of $2.39 billion. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. Synopsys’s revenue was up 65.6% on a year-over-year basis. During the same period in the prior year, the firm earned $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. As a group, sell-side analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the stock. Needham & Company LLC reaffirmed a “buy” rating on shares of Synopsys in a research note on Thursday, February 26th. Bank of America upgraded shares of Synopsys from an “underperform” rating to a “neutral” rating and dropped their target price for the company from $525.00 to $500.00 in a report on Monday, December 8th. Rosenblatt Securities cut their price target on shares of Synopsys from $560.00 to $530.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Morgan Stanley reiterated an “equal weight” rating and set a $480.00 price target (down from $550.00) on shares of Synopsys in a report on Wednesday, February 25th. Finally, Wells Fargo & Company lowered their price objective on Synopsys from $500.00 to $450.00 and set an “equal weight” rating for the company in a research report on Thursday, February 26th. Eight research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $531.00.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.